Results 221 to 230 of about 83,612 (293)

Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre Study

open access: yesLiver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background & Aims Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) go along with reduced health‐related quality of life (HRQOL). Variant syndromes, that is, conditions with features of both PBC/PSC and AIH, are associated with higher clinical complexity and worse prognosis. Studies on HRQOL
Natalie Uhlenbusch   +34 more
wiley   +1 more source

Maternal Diet Quality and Third Trimester Depression: Insights From a Nepali Birth Cohort Study

open access: yesMaternal &Child Nutrition, Volume 22, Issue 1, March 2026.
ABSTRACT Maternal diet quality and perinatal depression significantly impact maternal and child health, yet their relationship remains underexplored in low‐resource settings. This cross‐sectional study examined the association between overall diet quality and risk of depression during the third trimester among 296 pregnant women receiving antenatal ...
Kalpana Chaudhary   +12 more
wiley   +1 more source

Development of the Japanese Version of the Brief Dimensional Apathy Scale (b‐J‐DAS): Multidimensional Apathy in Dementia

open access: yesPsychogeriatrics, Volume 26, Issue 2, March 2026.
ABSTRACT Background Apathy is a common symptom in degenerative diseases such as dementia. In this study, we developed the Japanese version of the brief Dimensional Apathy Scale (b‐J‐DAS), which requires caregivers to rate patient apathy using three apathy sub‐scales: executive, emotional and initiation.
Yuka Hirayama   +3 more
wiley   +1 more source

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Metabolic disorders are risk factors for Alzheimer's disease (AD), although underlying mechanisms remain unclear. We investigated the relationship between peripheral metabolic markers – adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) – and AD.
Caroline Dallaire‐Théroux   +15 more
wiley   +1 more source

Association Between Peripheral IL‐6 Levels in the Acute Stage of Stroke and Poststroke Depression: A Systematic Review and Meta‐Analysis

open access: yesBrain and Behavior, Volume 16, Issue 2, February 2026.
This is a meta‐analysis on the relationship between IL‐6 concentration in the acute phase of stroke and poststroke depression. Higher peripheral IL‐6 concentrations in the acute stage of stroke are closely related to the risk of PSD; collecting samples within 1 day after stroke onset and evaluating depression post discharge are recommended.
Hongmin Gong   +7 more
wiley   +1 more source

Cardiometabolic Index as a Mediator in the Association Between Estimated Glucose Disposal Rate and Depressive Symptoms: A Population‐Based Study

open access: yesBrain and Behavior, Volume 16, Issue 2, February 2026.
This cross‐sectional study included individuals who took part in the NHANES from 2003 to 2018. Our results demonstrated that higher eGDR correlates with lower likelihood of depressive symptoms, with CMI acting as a mediator. Reducing insulin resistance and monitoring CMI could help decrease the occurrence of depression.
Mimi Li   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy